Overview

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Glyburide
Metformin
Criteria
Children ages 9-16 years with a diagnosis of type 2 diabetes mellitus who are not
adequately controlled with diet and exercise, with or without oral hypoglycemic therapy,
and have an HbA1c greater than 6.4%